Paul Tudor Jones II's position in Resmed is currently worth $37.6 Million. That's 0.47% of their equity portfolio (38th largest holding). The first Resmed trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 21 more times and sold shares on 21 occasions. The stake costed the investor $27.7 Million, netting the investor a gain of 36% so far.